Trial intelligence / Profile preview

Dexmedetomidine versus remifentanil for videolaryngoscope-guided endotracheal intubation in patients with neck trauma

IRCT20220307054213N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in None comparing Dexmedetomidine arm with Remifentanil arm (2 arms). Primary endpoints: Time required for intubation, Heart rate and 2 more. Started Apr 2022; status: completed.

02

Drugs

dexmedetomidineremifentanil

Beyond the preview

Go deeper on IRCT20220307054213N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220307054213N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call